IDH1 and astrocytoma (excluding glioblastoma): Many of the studies carried out before the last WHO resolution did not consider the current characteristics that our study considered, for example, the importance of analyzing the mutation in the IDH gene as a differentiating factor between grade 4 astrocytomas and GBMs.